Literature DB >> 28919290

Utility and limitations of long-term monitoring of atrial fibrillation using an implantable loop recorder.

Randall Lee1, Suneet Mittal2.   

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia diagnosed and treated in the world. The treatment of patients' symptoms as well as the prevention of stroke and heart failure is dependent on accurate detection and characterization of AF. A variety of electrocardiographic (ECG) monitoring techniques are being used for these purposes. However, these intermittent ECG monitoring techniques have been shown to underdiagnose AF events while having limited ability to characterize AF burden and density. Continuous long-term implantable loop recorder (ILR)-based ECG monitoring has been designed to overcome these limitations. This technology is being increasingly used to diagnose episodes of AF in high-risk patients and to improve characterization of AF episodes in patients with known AF. This review aims to review the potential clinical utility of ILR-based ECG monitoring while highlighting some inherent limitations of the current technology. An understanding of these limitations is important when considering the use of ILR-based ECG monitoring and clinical decision making based on the information being stored within these devices.
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; ECG monitoring; Implantable loop recorder; Limitations; Technology; Utility

Mesh:

Year:  2017        PMID: 28919290     DOI: 10.1016/j.hrthm.2017.09.009

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  7 in total

1.  Detection of atrial fibrillation using an implantable loop recorder following cryptogenic stroke: implications for post-stroke electrocardiographic monitoring.

Authors:  Nicolle S Milstein; Dan L Musat; James Allred; Amber Seiler; Jacqueline Pimienta; Susan Oliveros; Advay G Bhatt; Mark Preminger; Tina Sichrovsky; Richard E Shaw; Suneet Mittal
Journal:  J Interv Card Electrophysiol       Date:  2019-10-14       Impact factor: 1.900

2.  European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin.

Authors:  Marta Rubiera; Ana Aires; Kateryna Antonenko; Sabrina Lémeret; Christian H Nolte; Jukka Putaala; Renate B Schnabel; Anil M Tuladhar; David J Werring; Dena Zeraatkar; Maurizio Paciaroni
Journal:  Eur Stroke J       Date:  2022-06-03

Review 3.  Subcutaneouscardiac Rhythm Monitors: A Comprehensive Review.

Authors:  Gaurav Aggarwal; Saurabh Aggarwal; Venkata Alla; Bharat Narasimhan; Kyungmoo Ryu; Courtney Jeffery; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2021-02-28

4.  Predictive value of P wave terminal force in lead V1 for atrial fibrillation: A meta-analysis.

Authors:  Zhuoshan Huang; Zhenda Zheng; Bingyuan Wu; Leile Tang; Xujing Xie; Ruimin Dong; Yanting Luo; Suhua Li; Jieming Zhu; Jinlai Liu
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-02-05       Impact factor: 1.468

5.  Duration of Implantable Cardiac Monitoring and Detection of Atrial Fibrillation in Ischemic Stroke Patients: A Systematic Review and Meta-Analysis.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Martin Köhrmann; Valeria Caso; Fabienne Perren; Lina Palaiodimou; Spyridon Deftereos; Sotirios Giannopoulos; John Ellul; Christos Krogias; Dimitris Mavridis; Sokratis Triantafyllou; Anne W Alexandrov; Peter D Schellinger; Andrei V Alexandrov
Journal:  J Stroke       Date:  2019-09-30       Impact factor: 6.967

Review 6.  The Miniaturization of Cardiac Implantable Electronic Devices: Advances in Diagnostic and Therapeutic Modalities.

Authors:  Richard G Trohman; Henry D Huang; Parikshit S Sharma
Journal:  Micromachines (Basel)       Date:  2019-09-21       Impact factor: 2.891

7.  The BIOMONITOR III Injectable Cardiac Monitor: Clinical Experience with a Novel Injectable Cardiac Monitor.

Authors:  Nico Reinsch; Anna Füting; Dennis Höwel; Kars Neven
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.